Innovation Pharmaceuticals Inc (IPIX)

[sox040713]

The most recent short interest is < 1% of the OS and the most recent failure-to-deliver # is a measly 1500 shares. IMHO interpreting short volume as actual short sales is misleading. Please check out these two posts for some detailed explanations.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=132584168

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=133263103

The official short interest and failure-to-deliver data can be seen here.

http://otce.finra.org/ESI

https://www.sec.gov/help/foiadocsfailsdatahtm.html

11. I read on an internet chat room or website that a specific security has a large number of fails; are these sources reliable?

Investors can and should verify the number of failures to deliver in a specific security by checking publicly available data on failures to deliver. The Commission publishes on its website failures to deliver data for all equity securities, regardless of the fails level, twice per month. For current failures to deliver information, see http://www.sec.gov/foia/docs/failsdata.htm.

Investors should always be cautious that issuers, promoters, or shareholders may be seeking to stimulate buying interest by making false, misleading or unfounded statements in internet chat rooms or other such forums about alleged large “naked” short positions in some smaller issuers. Some individuals may encourage other investors to buy these issuers’ securities by claiming that there will be an imminent short squeeze, in which the alleged “naked” short sellers will be forced to cover open short positions at increasing prices. These claims in fact may be false.

https://www.sec.gov/investor/pubs/regsho.htm